PIMOZIDE Side Effects

6377408-0 | Anxiety, Dry Skin, Parkinsonism, Somnolence
on Sep 16, 2009 Male patient from UNITED STATES , 37 years of age, was diagnosed with tourette's disorder and was treated with Pimozide (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), dry skin, parkinsonism, somnolence. Pimozide dosage: . During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), TIAPRIDE (View Tiapride Review and Tiapride Label ), BOTULINUM TOXIN (View Botulinum Toxin Review and Botulinum Toxin Label ), ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ), SELECTIVE SEROTONIN REUPTAKE INHIBITORS (View Selective Serotonin Reuptake Inhibitors Review and Selective Serotonin Reuptake Inhibitors Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ).

5129926-0 | Fatigue
Patient was taking Pimozide (View Usage). Patient had the following side effects: fatigue on Oct 10, 2006 from GERMANY Additional patient health information: Female patient , 46 years of age, . Pimozide dosage: 40 Mg Oral.

5055146-4 | Escherichia Sepsis, Fall, Malaise, Vomiting
Adverse event was reported on Jul 10, 2006 by a Female patient taking Pimozide (View Usage) (Dosage: 4 Milligram Oral) . Location: FRANCE , 81 years of age, After Pimozide was administered, patient had the following side effects: escherichia sepsis, fall (What is fall?), malaise, vomiting. Patient was hospitalized.

5027836-0 | Hyperkinesia, Insomnia
on Jun 02, 2006 Male patient from SPAIN , 45 years of age, was treated with Pimozide (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkinesia, insomnia. Pimozide dosage: 4 Milligram Oral. During the same period patient was treated with RISPERIDONE (37 Milligram Intramuscular) (View Risperidone Review and Risperidone Label ), LEVOMEPROMAZINE (50 Milligram Oral) (View Levomepromazine Review and Levomepromazine Label ), FLUOXETINE HYDROCHLORIDE (20 Milligram Oral) (View Fluoxetine Hydrochloride Review and Fluoxetine Hydrochloride Label ).


5009006-5 | Bradykinesia, Dysarthria, Dyskinesia, Dystonia, Fall, Gait Disturbance, Hyperreflexia
on May 04, 2006 Male patient from ITALY , 54 years of age, was diagnosed with agitation, paranoia and was treated with Pimozide (View Usage). Patient had the following side effects: bradykinesia, dysarthria, dyskinesia, dystonia (What is dystonia?), fall (What is fall?), gait disturbance, hyperreflexia. Pimozide dosage: 200 Milligram. During the same period patient was treated with HALOPERIDOL (View Haloperidol Review and Haloperidol Label ). Patient was hospitalized.

4911208-0 | Extrapyramidal Disorder, Fall, Gait Disturbance, Muscle Rigidity, Parkinsonism
Patient was taking Pimozide (View Usage). After Pimozide was administered, patient had the following side effects: extrapyramidal disorder, fall (What is fall?), gait disturbance, muscle rigidity, parkinsonism on Jan 31, 2006 from GERMANY Additional patient health information: Male patient , 52 years of age, was diagnosed with mental disorder, vertigo and. Pimozide dosage: Oral. During the same period patient was treated with FLUNITRAZEPAM (Oral) (View Flunitrazepam Review and Flunitrazepam Label ), TRAZADONE (1 Tablet, Oral) (View Trazadone Review and Trazadone Label ), BETHAHISTINE (Oral) (View Bethahistine Review and Bethahistine Label ), PENTOXIFYLLINE (Oral) (View Pentoxifylline Review and Pentoxifylline Label ), MOLSIDOMINE (View Molsidomine Review and Molsidomine Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ). Patient was hospitalized.

4885793-1 | Condition Aggravated, Dystonia
Adverse event was reported on Jan 05, 2006 by a Female patient taking Pimozide (View Usage) (Dosage: ) . Location: JAPAN , 27 years of age, Patient experienced the following unwanted or unexpected effects: condition aggravated, dystonia (What is dystonia?). During the same period patient was treated with ZOTEPINE (View Zotepine Review and Zotepine Label ), PIPAMPERONE (View Pipamperone Review and Pipamperone Label ), TRIHEXIPHENYDIL (View Trihexiphenydil Review and Trihexiphenydil Label ), DANTROLENE (View Dantrolene Review and Dantrolene Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), PEROSPIRONE (View Perospirone Review and Perospirone Label ).

4879741-8 | Extrapyramidal Disorder, Sleep Disorder
on Dec 27, 2005 Female patient from NETHERLANDS , 43 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?) and was treated with Pimozide (View Usage). Patient had the following side effects: extrapyramidal disorder, sleep disorder (What is sleep disorder?). Pimozide dosage: 12 Milligram, Oral. Patient was hospitalized.

4851315-4 | Breast Cyst
on Dec 01, 2005 Female patient from AUSTRALIA , 51 years of age, was diagnosed with schizophrenia and was treated with Pimozide (View Usage). After Pimozide was administered, patient had the following side effects: breast cyst. Pimozide dosage: 16 Milligram Oral.

4820740-X | Lichenoid Keratosis, Psoriasis, Rash Erythematous, Rash Papular, Rash Pustular
Patient was taking Pimozide (View Usage). Patient experienced the following unwanted or unexpected effects: lichenoid keratosis, psoriasis, rash erythematous, rash papular, rash pustular on Oct 26, 2005 from FRANCE Additional patient health information: Male patient , 38 years of age, was diagnosed with anxiety (What is anxiety?) and. Pimozide dosage: 4 Mg, Oral. During the same period patient was treated with ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), CODEINE (View Codeine Review and Codeine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

4815502-3 | Extrapyramidal Disorder, Oropharyngeal Spasm, Somnolence
Adverse event was reported on Oct 21, 2005 by a Female patient taking Pimozide (View Usage) (Dosage: Oral) . Location: GERMANY , 61 years of age, Patient had the following side effects: extrapyramidal disorder, oropharyngeal spasm, somnolence. During the same period patient was treated with HALOPERIDOL (Oral) (View Haloperidol Review and Haloperidol Label ), AMITRIPTYLINE HCL (Oral) (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ).

4803438-3 | Blood Pressure Increased, Electrocardiogram Qt Prolonged, Electrocardiogram T Wave Peaked, Overdose, Respiratory Rate Increased, Suicide Attempt
on Sep 28, 2005 Male patient from FRANCE , 37 years of age, was treated with Pimozide (View Usage). After Pimozide was administered, patient had the following side effects: blood pressure increased, electrocardiogram qt prolonged, electrocardiogram t wave peaked, overdose, respiratory rate increased, suicide attempt. Pimozide dosage: Oral. During the same period patient was treated with BROMAZEPAM (View Bromazepam Review and Bromazepam Label ). Patient was hospitalized.

4781600-6 | Delusion, Hallucination, Overdose, Suicide Attempt
on Sep 19, 2005 Male patient from TURKEY , 65 years of age, was diagnosed with schizophrenia and was treated with Pimozide (View Usage). Patient experienced the following unwanted or unexpected effects: delusion, hallucination, overdose, suicide attempt. Pimozide dosage: 80 Milligram. During the same period patient was treated with THIORIDAZINE (100 Milligram) (View Thioridazine Review and Thioridazine Label ). Patient was hospitalized.

4777349-6 | Drooling, Dysphagia, Parkinsonism, Restlessness, Sedation, Tardive Dyskinesia
Patient was taking Pimozide (View Usage). Patient had the following side effects: drooling, dysphagia, parkinsonism, restlessness, sedation, tardive dyskinesia on Jun 24, 2005 from JAPAN Additional patient health information: Male patient , 63 years of age, was diagnosed with vascular dementia and. Pimozide dosage: 1.5 Milligram/6 Milligram/3 Milligram, Oral. During the same period patient was treated with TIAPRIDE HYDROCHLORIDE (100 Milligram/75 Milligram, Oral) (View Tiapride Hydrochloride Review and Tiapride Hydrochloride Label ).

4743699-2 | Atrial Fibrillation, Electrocardiogram Qt Prolonged
Adverse event was reported on Jul 28, 2005 by a Male patient taking Pimozide (View Usage) (Dosage: 2 Milligram) was diagnosed with schizophrenia and. Location: UNITED KINGDOM , 37 years of age, After Pimozide was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), electrocardiogram qt prolonged. During the same period patient was treated with CLOZAPINE (25 Milligram Oral) (View Clozapine Review and Clozapine Label ), RISPERADONE (Oral) (View Risperadone Review and Risperadone Label ), HALOPERIDOL (Oral) (View Haloperidol Review and Haloperidol Label ), DESLORATADINE (View Desloratadine Review and Desloratadine Label ), PROCYCLIDINE HYDROCHLORIDE 2MG TAB (View Procyclidine Hydrochloride 2mg Tab Review and Procyclidine Hydrochloride 2mg Tab Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

4737063-X | Extrapyramidal Disorder
on Jul 28, 2005 Female patient from NEW ZEALAND , 68 years of age, was diagnosed with anxiety (What is anxiety?) and was treated with Pimozide (View Usage). Patient experienced the following unwanted or unexpected effects: extrapyramidal disorder. Pimozide dosage: 2 Milligram. During the same period patient was treated with AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ). Patient was hospitalized.

4729886-8 | Anxiety, Restlessness
on Jul 12, 2005 Male patient from GERMANY , 49 years of age, was treated with Pimozide (View Usage). Patient had the following side effects: anxiety (What is anxiety?), restlessness. Pimozide dosage: See Image. Patient was hospitalized.

4705917-6 | Drooling, Dysphagia, Parkinsonism, Restlessness, Sedation, Tardive Dyskinesia
Patient was taking Pimozide (View Usage). After Pimozide was administered, patient had the following side effects: drooling, dysphagia, parkinsonism, restlessness, sedation, tardive dyskinesia on Jun 24, 2005 from Additional patient health information: Male patient , 63 years of age, was diagnosed with vascular dementia and. Pimozide dosage: 1.5 Milligram/6 Milligram/3 Milligram Oral. During the same period patient was treated with TIAPRIDE HYDROCHLORIDE (100 Milligram/75 Milligram Oral) (View Tiapride Hydrochloride Review and Tiapride Hydrochloride Label ).

4679571-6 | Cardiac Arrest, Electrocardiogram Qt Prolonged, Torsade De Pointes
Adverse event was reported on May 24, 2005 by a Male patient taking Pimozide (View Usage) (Dosage: 10 Milligram, Oral) was diagnosed with tourette's disorder and. Location: , 36 years of age, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), electrocardiogram qt prolonged, torsade de pointes. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ). Patient was hospitalized.

4627744-0 | Dystonia, Gait Disturbance
on Mar 22, 2005 Female patient from , 30 years of age, was treated with Pimozide (View Usage). Patient had the following side effects: dystonia (What is dystonia?), gait disturbance. Pimozide dosage: . During the same period patient was treated with ZOTEPINE (View Zotepine Review and Zotepine Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ).

4627739-7 | Parkinsonism, Somnolence
on Mar 22, 2005 Male patient from , 14 years of age, was treated with Pimozide (View Usage). After Pimozide was administered, patient had the following side effects: parkinsonism, somnolence. Pimozide dosage: 2 Milligram Oral. During the same period patient was treated with FLUVOXAMINE MALEATE (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ). Patient was hospitalized.

4627723-3 | Angina Pectoris, Electrocardiogram Qt Prolonged, Electrocardiogram St Segment Depression, Headache, Hyperhidrosis, Hypotension, Loss Of Consciousness, Malaise
Patient was taking Pimozide (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, electrocardiogram qt prolonged, electrocardiogram st segment depression, headache (What is headache?), hyperhidrosis, hypotension, loss of consciousness, malaise on Mar 23, 2005 from Additional patient health information: Male patient , 36 years of age, . Pimozide dosage: 2 Milligram. During the same period patient was treated with NEFAZODONE HCL (View Nefazodone Hcl Review and Nefazodone Hcl Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

4613883-7 | Diabetes Mellitus
Adverse event was reported on Mar 09, 2005 by a Female patient taking Pimozide (View Usage) (Dosage: 4 Milligram) was diagnosed with schizophrenia and. Location: , 54 years of age, Patient had the following side effects: diabetes mellitus. Patient was hospitalized.

4557831-7 | Musculoskeletal Stiffness, Parkinson's Disease, Tremor
on Jan 07, 2005 Male patient from , 55 years of age, was diagnosed with mental disorder and was treated with Pimozide (View Usage). After Pimozide was administered, patient had the following side effects: musculoskeletal stiffness, parkinson's disease (What is parkinson's disease?), tremor. Pimozide dosage: .